Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. Huillard
OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort From the AcSé Trial.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P3.03-01 BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients With Primary Melanoma
PLoS ONE
Multidisciplinary
Biomarker Analysis of On-Treatment and at Progression Biopsies From BRIM7 - A Phase 1B Trial of Combined Vemurafenib and Cobimetinib Treatment in BRAF V600 Mutated Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
BRAF -V600 Mutational Status Affects Recurrence Patterns of Melanoma Brain Metastasis
International Journal of Cancer
Cancer Research
Oncology
Targeted Treatment of Papillary Craniopharyngiomas Harboring BRAF V600E Mutations
Cancer
Cancer Research
Oncology
Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices
Current Oncology
Oncology
Targeted Therapy for Patients With BRAF-Mutant Lung Cancer Results From the European EURAF Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-68 Early SBRT to the Primary Tumor May Overcome the Icotinib Resistance in Patients With Advanced NSCLC Harboring EGFR Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
